Zijun Huo

548 total citations
26 papers, 350 citations indexed

About

Zijun Huo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zijun Huo has authored 26 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zijun Huo's work include Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (7 papers) and Virus-based gene therapy research (4 papers). Zijun Huo is often cited by papers focused on Pluripotent Stem Cells Research (7 papers), CRISPR and Genetic Engineering (7 papers) and Virus-based gene therapy research (4 papers). Zijun Huo collaborates with scholars based in China, United States and Taiwan. Zijun Huo's co-authors include Jian Tu, Yanchun Chen, Shuanhu Zhou, Lingyun Zhang, Shenming Wang, Ruiying Zhao, Weiwei Bao, Xin Wang, Dung‐Fang Lee and Qi Su and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and Endocrinology.

In The Last Decade

Zijun Huo

24 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zijun Huo China 11 177 79 68 65 52 26 350
Qungen Xiao China 13 193 1.1× 46 0.6× 40 0.6× 81 1.2× 58 1.1× 23 375
Zhangqi Dou China 12 146 0.8× 60 0.8× 29 0.4× 69 1.1× 60 1.2× 21 329
Jyotidarsini Mohanty United States 7 287 1.6× 67 0.8× 49 0.7× 36 0.6× 86 1.7× 10 421
Silin Wu China 8 94 0.5× 30 0.4× 29 0.4× 62 1.0× 41 0.8× 19 248
Kazuyuki Kuwayama Japan 10 131 0.7× 98 1.2× 64 0.9× 36 0.6× 25 0.5× 30 323
Yuejia Song China 10 208 1.2× 185 2.3× 51 0.8× 90 1.4× 84 1.6× 21 506
Leena Paul United States 10 276 1.6× 22 0.3× 64 0.9× 79 1.2× 70 1.3× 15 466
Jiangang Yu China 14 166 0.9× 25 0.3× 56 0.8× 81 1.2× 93 1.8× 23 386
Rosanna Bagnulo Italy 12 281 1.6× 38 0.5× 54 0.8× 74 1.1× 108 2.1× 36 515
Federica Parodi Italy 12 330 1.9× 121 1.5× 71 1.0× 164 2.5× 120 2.3× 21 566

Countries citing papers authored by Zijun Huo

Since Specialization
Citations

This map shows the geographic impact of Zijun Huo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zijun Huo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zijun Huo more than expected).

Fields of papers citing papers by Zijun Huo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zijun Huo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zijun Huo. The network helps show where Zijun Huo may publish in the future.

Co-authorship network of co-authors of Zijun Huo

This figure shows the co-authorship network connecting the top 25 collaborators of Zijun Huo. A scholar is included among the top collaborators of Zijun Huo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zijun Huo. Zijun Huo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huo, Zijun, Jin Li, Bo Lin, et al.. (2025). CircPSD3 aggravates tumor progression by maintaining TCA cycle and mitochondrial function via regulating SUCLG2 in thyroid carcinoma. Cell Death and Disease. 16(1). 590–590.
2.
Xu, An, Donghui Wang, Julian A. Gingold, et al.. (2025). Mutant p53 confers chemoresistance by activating KMT5B-mediated DNA repair pathway in nasopharyngeal carcinoma. Cancer Letters. 625. 217736–217736. 1 indexed citations
3.
Chen, Weidong, Yutong Zou, Fang Ji, et al.. (2025). Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. Journal for ImmunoTherapy of Cancer. 13(8). e011091–e011091. 1 indexed citations
4.
Zhang, Pengyuan, Zijun Huo, Yanbing Li, et al.. (2025). Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-κB signaling. Journal of Endocrinological Investigation. 48(5). 1121–1136.
5.
He, Weiman, Zhen Cheng, Zijun Huo, et al.. (2023). STRA6 Promotes Thyroid Carcinoma Progression via Activation of the ILK/AKT/mTOR Axis in Cells and Female Nude Mice. Endocrinology. 164(3). 3 indexed citations
6.
Hong, Shubin, Bo Lin, Minjie Xu, et al.. (2023). Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma. EBioMedicine. 90. 104497–104497. 9 indexed citations
7.
Zhou, Fenghua, Yingjun Guan, Qi Su, et al.. (2022). The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis. Cells. 11(3). 572–572. 33 indexed citations
8.
Chen, Li, Li Xiong, Jin Li, et al.. (2020). Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p. The Journal of Clinical Endocrinology & Metabolism. 105(8). 2704–2718. 12 indexed citations
9.
Huo, Zijun, Jian Tu, Dung‐Fang Lee, & Ruiying Zhao. (2020). Engineering Mutation Clones in Mammalian Cells with CRISPR/Cas9. Methods in molecular biology. 2108. 355–369. 2 indexed citations
10.
Su, Jie, Zijun Huo, Julian A. Gingold, et al.. (2019). Genomic Integrity Safeguards Self-Renewal in Embryonic Stem Cells. Cell Reports. 28(6). 1400–1409.e4. 10 indexed citations
11.
Zhou, Ruoji, An Xu, Donghui Wang, et al.. (2018). A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing. Stem Cell Research. 27. 131–135. 7 indexed citations
12.
Xu, An, Ruoji Zhou, Jian Tu, et al.. (2018). Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing. Stem Cell Research. 29. 215–219. 7 indexed citations
13.
Liu, Mo, Linchao Lu, Ruoji Zhou, et al.. (2018). Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation. Stem Cell Research. 33. 36–40. 2 indexed citations
14.
Tu, Jian, Zijun Huo, Mo Liu, et al.. (2018). Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase. Stem Cell Research. 28. 29–32. 10 indexed citations
15.
Huo, Zijun, Jian Tu, An Xu, et al.. (2018). Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing. Stem Cell Research. 34. 101360–101360. 7 indexed citations
16.
17.
Tu, Jian, Zijun Huo, Julian A. Gingold, et al.. (2017). The histogenesis of Ewing Sarcoma. PubMed. 1(2). 20 indexed citations
18.
Huo, Zijun, Shuang Yu, Shubin Hong, et al.. (2016). A systematic review and meta-analysis of the risk of diarrhea associated with vandetanib treatment in carcinoma patients. OncoTargets and Therapy. 9. 3621–3621. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026